Yahoo Web Search

Search results

  1. 5 days ago · SAN ANTONIO, May 9, 2024 – The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in National Institutes of Health funding over five years through a cooperative agreements research project grant, known as a U01 grant.

  2. 5 days ago · The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in National Institutes of Health funding over five years through a cooperative agreements research project grant, known as a U01 grant. “We are excited about receiving the U01 award because it will enable us to move […]

  3. 3 days ago · The grant from the National Institutes of Health will take a mutated version of the chlamydia STD to determine if it works as a vaccine against a disease that affects about 4 million people in the ...

  4. 5 days ago · May 9 2024 The University of Texas Health Science Center at San Antonio. The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11...

  5. 4 days ago · The University of Texas Health Science Center at San Antonio (UT Health San Antonio) will direct a team of researchers to investigate a novel oral vaccine for chlamydia, the most reported...

  6. 5 days ago · Published: May 9, 2024, 12:15 PM. Tags: health, ut health san antonio, chlamydia. The study of an oral vaccine that could protect against chlamydia infection has been awarded approximately...

  7. 1 day ago · Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial.

  1. People also search for